{"id":188676,"date":"2015-03-06T20:46:55","date_gmt":"2015-03-07T01:46:55","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/health-care-sector-update-for-03062015-blrxicelaezs.php"},"modified":"2015-03-06T20:46:55","modified_gmt":"2015-03-07T01:46:55","slug":"health-care-sector-update-for-03062015-blrxicelaezs","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/health-care\/health-care-sector-update-for-03062015-blrxicelaezs.php","title":{"rendered":"Health Care Sector Update for 03\/06\/2015: BLRX,ICEL,AEZS"},"content":{"rendered":"<p><p>    Top Health Care Stocks  <\/p>\n<p>    JNJ -2.38%  <\/p>\n<p>    PZE -1.40%  <\/p>\n<p>    MRK -1.90%  <\/p>\n<p>    ABT -1.90%  <\/p>\n<p>    AMGN -3.42%  <\/p>\n<p>    Health care stocks were sharply lower in late trade with the    NYSE Health Care Sector Index dropping about 1.7% and shares of    health care companies in the S&P 500 down almost 1.9% as a    group.  <\/p>\n<p>    In company news, BioLineRx Ltd. ( BLRX ) retreated Friday    after the early-stage biotech company today priced a $25    million public offering of 12.5 million American depository    shares at $2 apiece, a nearly 29% discount to Thursday's    closing price for the stock.  <\/p>\n<p>    Each ADS is equal to 10 ordinary BLRX shares. The company plans    to use net proceeds to fund clinical trials of its BL-8040 drug    candidate to treat cute myeloid leukemia and for it BL-7010    experimental treatment for celiac disease.  <\/p>\n<p>    BLRX shares were down more than 27% in late afternoon trading    at $2.05 apiece, just a penny above their session low. The    stock has traded within a 52-week range of $1.20 to $3.28    apiece, rising nearly 11% over the past year prior to today's    decline.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>The rest is here:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.nasdaq.com\/article\/health-care-sector-update-for-03062015-blrxicelaezs-cm451808\/RK=0\/RS=7w3nlfe1r91odyNG5zPkhAfR8xI-\" title=\"Health Care Sector Update for 03\/06\/2015: BLRX,ICEL,AEZS\">Health Care Sector Update for 03\/06\/2015: BLRX,ICEL,AEZS<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Top Health Care Stocks JNJ -2.38% PZE -1.40% MRK -1.90% ABT -1.90% AMGN -3.42% Health care stocks were sharply lower in late trade with the NYSE Health Care Sector Index dropping about 1.7% and shares of health care companies in the S&#038;P 500 down almost 1.9% as a group. In company news, BioLineRx Ltd. ( BLRX ) retreated Friday after the early-stage biotech company today priced a $25 million public offering of 12.5 million American depository shares at $2 apiece, a nearly 29% discount to Thursday's closing price for the stock <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/health-care\/health-care-sector-update-for-03062015-blrxicelaezs.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[6],"tags":[],"class_list":["post-188676","post","type-post","status-publish","format-standard","hentry","category-health-care"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/188676"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=188676"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/188676\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=188676"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=188676"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=188676"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}